azatend O 200mg

Azatend O 200mg tablet consists of the active ingredient Azacitidine. This medication is specifically utilized for treating adults who have certain blood conditions, namely Myelodysplastic Syndrome (MDS), chronic myelomonocytic leukemia, and Acute Myeloid Leukemia (AML), particularly if these individuals are considered ineligible for a stem cell transplant. In the context of Myelodysplastic Syndrome, the bone marrow experiences a significant lack of proper function, leading to its inability to produce healthy blood cells effectively. Acute Myeloid Leukemia, on the other hand, is a severe type of bone marrow cancer that arises from the premature release of incompletely formed blood cells into the bloodstream. Lastly, chronic myelomonocytic leukemia represents a rare form of blood cancer characterized by an abnormal and increased number of monocytes, which are a specific type of white blood cell.